Antibiotic use and bacterial resistance;Consommation d'antibiotiques et resistance bacterienne

Annales Francaises d'Anesthesie et de Reanimation

Volumn 19, Issue 5, 2000, Pages 409-417

  Monnet, D L ^a  

^a Statens Serum I ^*  (Denmark)

Author keywords

Antibiotherapy; Bacterial resistance; Epidemiology; Nosocomial infections

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; DOSE RESPONSE; HOSPITAL INFECTION; MEDICAL DECISION MAKING; REVIEW; BACTERIUM; CROSS INFECTION; DRUG EFFECT; DRUG UTILIZATION; EUROPE; HUMAN; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIA; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; EUROPE; HUMANS;

EID: 0033945803     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(00)90211-9     Document Type: Article

References (24)

1. Finland M. Emergence of antibiotic-resistant bacteria. N Engl J M. 253:1955;909-922.
2. Voss A, Milatovic F, Wallrauch-Schwarz C, Rosdahl T, Braveny I. Methicillin-resistantStaphylococcus aureusin Europe. Eur J Clin Microbiol Infect Dis. 13:1994;50-55.
3. Hanberger H., Garcia-Rodriguez J.A., Gobernado M., Goossens H., Nisson L.E., Struelens M.J., et al. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. JAMA. 281:1999;67-71.
4. Schentag J.J., Hyatt J.M., Carr J.R., Paladino J.A., Birmingham M.C., Zimmer G.S., et al. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clin Infect Dis. 26:1998;1204-1214.
5. Rahal J.J., Urban C., Horn D., Freeman K., Segal-Maurer S., Maurer J., et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 280:1998;1233-1237.
6. McGowan J.E. Jr. Is antimicrobial resistance in hospital micro-organisms related to antibiotic use? Bull NY Acad M. 63:1987;253-268.
7. Levy S.B., Fitzgerald G.B., Macone A.B. Spread of antibiotic-resistant plasmids from chicken to chicken and from chicken to man. Nature. 260:1976;40-42.
8. Levy S.B., Fitzgerald G.B., Macone A.B. Changes in intestinal flora of farm personnel after introduction or a tetracycline-supplemented feed on a farm. N Engl J M. 295:1976;583-588.
9. Richard P., Delangle M.H., Merrien D., Barille S., Reynaud A., Minozzi C., Richet H. Fluoroquinolone use and fluoroquinolone resistance: is there an association? Clin Infect Dis. 19:1994;54-59.
10. Monnet D., Gaynes R., Tenover F., McGowan J. The ICARE pilot hospitals. Ceftazidime-resistant Pseudomonas aeruginosa (PA) and ceftazidime (CFZ) usage in NNIS hospitals: preliminary results of Project ICARE Phase One. Infect Control Hosp Epidemiol. 16:(4-Part 2):1995;P19.
11. Guillemot D., Carbon C., Balkau B., Geslin P., Lecoeur H., Vauzelle-Kervroedan F., et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA. 279:1998;365-370.
12. Aubert G., Vautrin A.C., Pain P., Michel V.P., Zeni F., Rusch P. The therapeutic interest of restricting prescription of fluoroquinolones in an intensive care unit. Abstracts of the 35th ICAAC ; 1995 Sep 17-20 ; San Francisco, CA. 1995;110 American Society for Microbiology, Washington, DC. abstr. E140.
13. Frank M.O., Batteiger B.E., Sorensen S.J., Hartstein A.I., Carr J.A., McComb J.S., et al. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Clin Perform Qual Health Care. 5:1997;180-188.
14. Monnet D.L. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect Control Hosp Epidemiol. 19:1998;552-559.
15. McGowan J.E. Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol. 15:1994;478-483.
16. Monnet D.L., Archibald L.K., Phillips L., Tenover F.C., McGowan J.E. Jr, Gaynes R.P., et al. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Infect Control Hosp Epidemiol. 19:1998;388-394.
17. Maslow J., Mulligan M.E. Epidemiologic typing systems. Infect Control Hosp Epidemiol. 17:1996;595-604.
18. Olive D.M., Bean P. Principles and applications of methods for DNA-based typing of microbial organisms. J Clin Microbiol. 37:1999;1661-1669.
19. Tenover F.C., Arbeit R.D., Goering R.V. The Molecular Typing Working Group of the Society for Healthcare Epidemiology of America. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Infect Control Hosp Epidemiol. 18:1997;426-439.
20. López-Lozano J.M., Monnet D.L., Yagüe A., Burgos A., Gonzalo N., Campillos P., et al. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents. 14:2000;21-31.
21. Pittet D., Furrer H.J. Réduction de personnel et infections nosocomiales. Swiss-NOSO. 4:1997;1-3 Available from : URL : http : //www. hospvd. ch/swiss-noso/vo4nu1f. pdf.
22. Monnet D.L., Biddle J.W., Edwards J.R., Culver D.H., Tolson J.S., Martone W.J., et al. Evidence of interhospital transmission of extended-spectrum beta-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. Infect Control Hosp Epidemiol. 18:1997;492-498.
23. Bager F. DANMAP 98 - Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. 1999;Danish Zoonosis Centre, Copenhagen, Denmark, Available from : URL : http : //www. svs. dk/dk/Publikationer/Lgo_publ.htm.
24. Smith K.E., Besser J.M., Hedberg C.W., Leano F.T., Bender J.B., Wicklund J.H., et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N Engl J M. 340:1999;1525-1532.